Oh B, Lee KJ, Zaslawski C, Yeung A, Rosenthal D, Larkey L, Back M
The FDA has taken the position that semaglutide sodium is a different active ingredient from semaglutide base
The drug, according to a spokesperson for Amgen, has the potential to provide weight loss without a weight-loss plateau, meaning that there wont be a point when your weight-loss begins to plateau, and people can retain weight loss several months after they stop taking it (a key bottleneck in previous weight-loss drugs)
Now, while this does not mean you should run out and stock up on protein or amino acid supplements, it does stress the importance of maintaining a healthy intake if boosting glutathione is your end goal
Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems
This experience with mechanistically related drugs provides some reassurance about Retatrutides long-term profile